"The FDA rejected Moderna's application for filing because the company refused to follow very clear FDA guidance from 2024 to ...
The US pharma firm’s 40,000-person study suggested its new shot was more effective than a standard flu vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results